MXPA03003146A - Derivados de eritromicina de liberacion prolongada. - Google Patents

Derivados de eritromicina de liberacion prolongada.

Info

Publication number
MXPA03003146A
MXPA03003146A MXPA03003146A MXPA03003146A MXPA03003146A MX PA03003146 A MXPA03003146 A MX PA03003146A MX PA03003146 A MXPA03003146 A MX PA03003146A MX PA03003146 A MXPA03003146 A MX PA03003146A MX PA03003146 A MXPA03003146 A MX PA03003146A
Authority
MX
Mexico
Prior art keywords
extended release
long chain
erythromycin derivatives
erythromycin derivative
release erythromycin
Prior art date
Application number
MXPA03003146A
Other languages
English (en)
Spanish (es)
Inventor
Donald J Treacy Jr
Original Assignee
Advancis Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advancis Pharmaceuticals filed Critical Advancis Pharmaceuticals
Publication of MXPA03003146A publication Critical patent/MXPA03003146A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MXPA03003146A 2000-10-13 2001-10-12 Derivados de eritromicina de liberacion prolongada. MXPA03003146A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68998800A 2000-10-13 2000-10-13
US0133055 2001-10-12

Publications (1)

Publication Number Publication Date
MXPA03003146A true MXPA03003146A (es) 2004-12-06

Family

ID=24770642

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03003146A MXPA03003146A (es) 2000-10-13 2001-10-12 Derivados de eritromicina de liberacion prolongada.

Country Status (6)

Country Link
EP (1) EP1333807A4 (fr)
JP (1) JP2004528272A (fr)
AU (1) AU2002239232A1 (fr)
CA (1) CA2425688A1 (fr)
MX (1) MXPA03003146A (fr)
WO (1) WO2002038577A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
EP1811986B1 (fr) * 2004-11-04 2014-03-26 XenoPort, Inc. Formes posologiques orales a liberation prolongee d'un promedicament de la gabapentine

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3108046A (en) * 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
JPS49107855A (fr) * 1973-02-03 1974-10-14
JP2528652B2 (ja) * 1987-03-30 1996-08-28 エスエス製薬株式会社 持効性セフラジン製剤
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
AU8219191A (en) * 1990-06-14 1992-01-07 Kalmo Enterprises, Inc. Stable aqueous drug suspensions
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
JPH07267850A (ja) * 1994-03-28 1995-10-17 Eisai Co Ltd 不快味を防止した医薬組成物及びその製造方法
EP0826376B1 (fr) * 1995-05-02 2007-01-24 Taisho Pharmaceutical Co. Ltd Composition s'administrant par voie orale
US5858986A (en) * 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
US6010718A (en) * 1997-04-11 2000-01-04 Abbott Laboratories Extended release formulations of erythromycin derivatives
US5780604A (en) * 1997-09-26 1998-07-14 Abbott Laboratories 11,12-cyclic phosphite or phosphate derivatives of erythromycin and related macrolides
JP2000169364A (ja) * 1998-09-30 2000-06-20 Taisho Pharmaceut Co Ltd 経口製剤用粒子
CN1343128B (zh) * 1999-03-17 2010-04-21 第一制药株式会社 药物组合物
SI20244A (sl) * 1999-05-19 2000-12-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Granulacija v talini

Also Published As

Publication number Publication date
EP1333807A4 (fr) 2005-06-29
WO2002038577A3 (fr) 2002-09-19
CA2425688A1 (fr) 2002-05-16
WO2002038577A2 (fr) 2002-05-16
EP1333807A2 (fr) 2003-08-13
JP2004528272A (ja) 2004-09-16
AU2002239232A1 (en) 2002-05-21

Similar Documents

Publication Publication Date Title
DE60006070D1 (de) Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
AU2002229140A1 (en) Controlled release pharmaceutical composition
BR0106100B1 (pt) composição de gesso fixado, artigo, e, método para preparar uma composição de gesso fixado.
IL154507A0 (en) Process for making n-aryl-anthranilic acids and their derivatives
DE69902535D1 (de) Phenoxypropanolamin-derivate, verfahren zu ihrer herstellung und diese enthaltenden pharmazeutischen zusammensetzungen
EE05194B1 (et) Farmatseutiliste omadustega aminodikarbokslhappe derivaadid
DE50102147D1 (de) Acylphenylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ID26738A (id) Proses untuk memproduksi akrolein dan asam akrilat
DE60325461D1 (de) Pharmazeutische granulatzusammensetzungen mit sofortiger freisetzung und kontinuierliches verfahren zu ihrer herstellung
AU2001278980A1 (en) Coumarin derivatives useful as tnfalpha inhibitors
ATE296535T1 (de) Wässerige formulierungen und verfahren zu ihrer herstellung
AU2001236678A1 (en) Adamantyl derivatives as anti-cancer agents
CA2313878A1 (fr) Composition permettant d'eliminer les problemes de comportement chez les animaux de compagnie
DE60304599D1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
AU2001272293A1 (en) Device for administering an injectable product
ID29673A (id) Proses untuk pembuatan turunan-turunan resorsinol
MXPA03002901A (es) Derivados de acido propionico.
DE60113888D1 (de) Verpackung mit Mitteln zum Beweisen ihrer Unversehrtheit
ID29229A (id) Komposisi dan proses untuk pemindahan gas-gas asam
MXPA03003146A (es) Derivados de eritromicina de liberacion prolongada.
DE60131637D1 (de) Granulare waschmittelkomponente und verfahren zu ihrer herstellung
AU2002222750A1 (en) Pharmaceutical composition for intramuscular injection containing loxoprofen
ATE358470T1 (de) Pharmazeutische zusammensetzung mit kontrollierter freisetzung und verfahren zu ihrer herstellung
ATE244246T1 (de) Pyridothienodiazepine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ID17326A (id) Turunan-turunan asam 4-arilbutirat tersubstitusi sebagai inhibitor-inhibitor matriks metalloprotease